ATE365796T1 - Tumornekrosefaktor-rezeptoren 6 alpha& 6 beta - Google Patents

Tumornekrosefaktor-rezeptoren 6 alpha& 6 beta

Info

Publication number: ATE365796T1
Authority: AT; Austria
Prior art keywords: necrosis factor; tumor necrosis; tnfr; methods; beta
Prior art date: 1997-01-14

Application number

AT98901699T

Other languages

English (en)

Inventor

Reiner Gentz

Jian Ni

Reinhard Ebner

Guo-Liang Yu

Steven Ruben

Ping Feng

Original Assignee

Human Genome Sciences Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-01-14

Filing date

1998-01-13

Publication date

2007-07-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21883066&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE365796(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-01-13 Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc

2007-07-15 Application granted granted Critical

2007-07-15 Publication of ATE365796T1 publication Critical patent/ATE365796T1/de

Links

108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 title abstract 2
102000003298 tumor necrosis factor receptor Human genes 0.000 title abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
208000035475 disorder Diseases 0.000 abstract 2
210000000987 immune system Anatomy 0.000 abstract 2
239000000556 agonist Substances 0.000 abstract 1
239000005557 antagonist Substances 0.000 abstract 1
238000002405 diagnostic procedure Methods 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
102000039446 nucleic acids Human genes 0.000 abstract 1
108020004707 nucleic acids Proteins 0.000 abstract 1
150000007523 nucleic acids Chemical class 0.000 abstract 1
229920001184 polypeptide Polymers 0.000 abstract 1
102000004196 processed proteins & peptides Human genes 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1
102000004169 proteins and genes Human genes 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1
238000010188 recombinant method Methods 0.000 abstract 1
238000012216 screening Methods 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1
239000013598 vector Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Biomedical Technology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Immunology (AREA)
Cell Biology (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Plant Pathology (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT98901699T 1997-01-14 1998-01-13 Tumornekrosefaktor-rezeptoren 6 alpha& 6 beta ATE365796T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US3549697P	1997-01-14	1997-01-14

Publications (1)

Publication Number	Publication Date
ATE365796T1 true ATE365796T1 (de)	2007-07-15

Family

ID=21883066

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98901699T ATE365796T1 (de)	1997-01-14	1998-01-13	Tumornekrosefaktor-rezeptoren 6 alpha& 6 beta

Country Status (12)

Country	Link
US (2)	US8003386B1 (de)
EP (1)	EP1007659B1 (de)
JP (1)	JP2001507937A (de)
KR (1)	KR20000070174A (de)
CN (1)	CN1247567A (de)
AT (1)	ATE365796T1 (de)
AU (1)	AU729062C (de)
BR (1)	BR9806954A (de)
CA (1)	CA2277925A1 (de)
DE (1)	DE69837996T2 (de)
ES (1)	ES2286843T3 (de)
WO (1)	WO1998030694A2 (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7597886B2 (en)	1994-11-07	2009-10-06	Human Genome Sciences, Inc.	Tumor necrosis factor-gamma
US7429646B1 (en)	1995-06-05	2008-09-30	Human Genome Sciences, Inc.	Antibodies to human tumor necrosis factor receptor-like 2
US7888466B2 (en)	1996-01-11	2011-02-15	Human Genome Sciences, Inc.	Human G-protein chemokine receptor HSATU68
US7357927B2 (en)	1996-03-12	2008-04-15	Human Genome Sciences, Inc.	Death domain containing receptors
US6713061B1 (en)	1996-03-12	2004-03-30	Human Genome Sciences, Inc.	Death domain containing receptors
WO1997033904A1 (en)	1996-03-12	1997-09-18	Human Genome Sciences, Inc.	Death domain containing receptors
US6635743B1 (en)	1996-03-22	2003-10-21	Human Genome Sciences, Inc.	Apoptosis inducing molecule II and methods of use
US7964190B2 (en)	1996-03-22	2011-06-21	Human Genome Sciences, Inc.	Methods and compositions for decreasing T-cell activity
WO2000053755A2 (en) *	1999-03-08	2000-09-14	Genentech, Inc.	Compositions and methods for the treatment of tumor
ES2286843T3 (es)	1997-01-14	2007-12-01	Human Genome Sciences, Inc.	Receptores 6 alfa y 6 beta del factor de necrosis tumoral.
US7285267B2 (en)	1997-01-14	2007-10-23	Human Genome Sciences, Inc.	Tumor necrosis factor receptors 6α & 6β
AU9013998A (en) *	1997-07-21	1999-02-10	Zymogenetics Inc.	Tumor necrosis factor receptor ztnfr-5
CA2299619A1 (en) *	1997-08-06	1999-02-18	Regeneron Pharmaceuticals, Inc.	Human orphan receptor ntr-1
AU9376498A (en) *	1997-09-05	1999-03-22	University Of Washington	Tumor necrosis factor family receptors and ligands, encoding nucleic acids and related binding agents
ATE393222T1 (de)	1997-09-18	2008-05-15	Genentech Inc	Dcr3 polypeptid, ein tnfr homolog
AU1535699A (en) *	1997-11-24	1999-06-15	Apotech S.A.	Novel receptors opg-2
WO1999031128A2 (en) *	1997-12-16	1999-06-24	Incyte Pharmaceuticals, Inc.	Human tumor necrosis factor-r2-like proteins
DE19809978A1 (de) *	1998-03-09	1999-09-16	Basf Ag	Neuer Rezeptor aus der menschlichen Lunge
CA2324517A1 (en) *	1998-03-30	1999-10-07	Eli Lilly And Company	Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the tnf receptor superfamily
US6916907B1 (en)	1998-10-23	2005-07-12	Curagen Corporation	Nucleic acids encoding osteoprotegern-like proteins and methods of using same
EP1020521A1 (de) *	1998-12-09	2000-07-19	Eli Lilly And Company	Zusammensetzungen, die Fas Ligand Inhibitor ( FLINT ) Proteine enthalten, und ihre Anwendungen
WO2000037094A2 (en) *	1998-12-22	2000-06-29	Eli Lilly And Company	Therapeutic applications of flint polypeptides
WO2000046247A1 (en) *	1999-02-05	2000-08-10	Merck & Co., Inc.	Methods of use for dna molecules encoding m68, a tnf receptor-related protein
EP2357192A1 (de)	1999-02-26	2011-08-17	Human Genome Sciences, Inc.	Menschliches alpha-Endokin und Verfahren zu seiner Verwendung
EP1159286A4 (de) *	1999-03-04	2003-01-15	Human Genome Sciences Inc	Tumornekrosefaktor-rezeptoren 6 alpha und 6 beta
US6835814B1 (en)	1999-03-30	2004-12-28	Eli Lilly And Company	Protease resistant flint analogs
US6965012B1 (en) *	1999-03-30	2005-11-15	Eli Lilly And Company	Flint polypeptide analogs
CA2368760A1 (en) *	1999-03-30	2000-10-05	Eli Lilly And Company	Flint polypeptide analogs
DE60036199T2 (de) *	1999-03-30	2008-05-21	Eli Lilly And Co., Indianapolis	Proteaseresistente flint-analoge
US6627199B1 (en)	1999-07-09	2003-09-30	Amgen Inc	Isolation, identification and characterization of tmst2, a novel member of the TNF-receptor supergene family
EP1210435A1 (de)	1999-08-04	2002-06-05	Amgen Inc.	Fhm, EIN NEUES MITGLIED DER TUMOR NECROSIS FAKTOR (TNF) SUPERGEN FAMILIE
AU6517800A (en)	1999-08-04	2001-03-05	Amgen, Inc.	Ntr3, a member of the tnf-receptor supergene family
AU7053100A (en) *	1999-09-10	2001-04-10	Eli Lilly And Company	Flint analog compounds and formulations thereof
WO2001018041A2 (en) *	1999-09-10	2001-03-15	Eli Lilly And Company	Flint proteins and formulations thereof
AU6891800A (en) *	1999-09-10	2001-04-10	Eli Lilly And Company	Flint analog compounds and formulations thereof
AU2001282856A1 (en)	2000-06-15	2001-12-24	Human Genome Sciences, Inc.	Human tumor necrosis factor delta and epsilon
DE60143798D1 (de)	2000-06-16	2011-02-17	Cambridge Antibody Tech	Immunspezifisch bindende antikörper gegen blys
CN1331125A (zh) *	2000-06-26	2002-01-16	上海博德基因开发有限公司	一种新的多肽——人含细胞色素c结构域的tnfr/ngfr蛋白9.02和编码这种多肽的多核苷酸
AU2001286688A1 (en) *	2000-08-25	2002-03-13	Human Genome Sciences, Inc.	Tumor necrosis factor receptors 6alpha and 6beta
JP4309758B2 (ja)	2001-05-25	2009-08-05	ヒューマンジノームサイエンシーズ，インコーポレイテッド	Ｔｒａｉｌレセプターに免疫特異的に結合する抗体
ES2425738T3 (es)	2001-12-21	2013-10-17	Human Genome Sciences, Inc.	Proteínas de fusión de la albúmina
CA2496060C (en) *	2002-09-11	2015-08-04	Genentech, Inc.	Protein purification by ion exchange chromatography
NZ597082A (en)	2005-10-13	2013-11-29	Human Genome Sciences Inc	Methods and Compositions for Use in Treatment of Patients with Autoantibody Positive Diseases
US20090269345A1 (en) *	2005-12-23	2009-10-29	Rong Fan	CLN248 Antibody Compositions and Methods of Use
US20110229471A1 (en)	2008-11-26	2011-09-22	Cedars-Sinai Medical Center	Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease
US9221895B2 (en) *	2009-03-13	2015-12-29	The Trustees Of The University Of Pennsylvania	OX40/TRAIL fusion proteins
SG191716A1 (en)	2010-11-19	2013-08-30	Toshio Imai	Neutralizing anti-ccl20 antibodies
KR20240122922A (ko)	2013-03-27	2024-08-13	세다르스-신나이 메디칼 센터	Tl1a 기능 및 관련된 신호전달 경로의 저해에 의한 섬유증 및 염증의 완화 및 반전
CA2922704A1 (en)	2013-05-24	2014-11-27	Neil R. Cashman	Cell senescence markers as diagnostic and therapeutic targets
EP4105236A1 (de)	2013-07-19	2022-12-21	Cedars-Sinai Medical Center	Anti-tl1a (tnfsf15) antikörper zur behandlung von entzündlichen darmerkrankungen
CN109462996A (zh)	2016-03-17	2019-03-12	西达-赛奈医疗中心	通过rnaset2诊断炎性肠病的方法

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4847325A (en) *	1988-01-20	1989-07-11	Cetus Corporation	Conjugation of polymer to colony stimulating factor-1
US5194596A (en) *	1989-07-27	1993-03-16	California Biotechnology Inc.	Production of vascular endothelial cell growth factor
US5350836A (en) *	1989-10-12	1994-09-27	Ohio University	Growth hormone antagonists
DE69233441T2 (de)	1991-04-26	2005-10-13	Osaka Bioscience Institute, Suita	Menschliches Zelloberflächen-Antigen codierende DNA
KR960704938A (ko)	1993-10-14	1996-10-09	그리스토퍼 엘. 와이트	Fas 길항제 및 그의 용도(Fas Antagonists and Uses Thereof)
US5830469A (en)	1993-10-14	1998-11-03	Immunex Corporation	Fas antagonists and uses thereof
US5663070A (en)	1993-11-15	1997-09-02	Lxr Biotechnology Inc.	Recombinant production of a soluble splice variant of the Fas (Apo-1) antigen, fas TM
US5741667A (en) *	1994-05-27	1998-04-21	Genentech, Inc.	Tumor necrosis factor receptor-associated factors
US5632994A (en)	1994-06-14	1997-05-27	La Jolla Cancer Research Foundation	Fas associated proteins
EP0822984A4 (de)	1995-04-27	2000-05-03	Human Genome Sciences Inc	Rezeptor für humanen tumor nekrosis faktor
US5985614A (en) *	1996-08-30	1999-11-16	Human Genome Sciences, Inc.	Polynucleotides encoding interleukin-19
WO2000053755A2 (en)	1999-03-08	2000-09-14	Genentech, Inc.	Compositions and methods for the treatment of tumor
ES2286843T3 (es)	1997-01-14	2007-12-01	Human Genome Sciences, Inc.	Receptores 6 alfa y 6 beta del factor de necrosis tumoral.
US5885800A (en)	1997-02-04	1999-03-23	Smithkline Beecham Corporation	DNA encoding tumor necrosis related receptor, TR4
AU7830398A (en)	1997-06-11	1998-12-30	Human Genome Sciences, Inc.	Human tumor necrosis factor receptor tr9
AU9013998A (en)	1997-07-21	1999-02-10	Zymogenetics Inc.	Tumor necrosis factor receptor ztnfr-5
CA2299619A1 (en)	1997-08-06	1999-02-18	Regeneron Pharmaceuticals, Inc.	Human orphan receptor ntr-1
AU9376498A (en)	1997-09-05	1999-03-22	University Of Washington	Tumor necrosis factor family receptors and ligands, encoding nucleic acids and related binding agents
ATE393222T1 (de) *	1997-09-18	2008-05-15	Genentech Inc	Dcr3 polypeptid, ein tnfr homolog
AU1535699A (en)	1997-11-24	1999-06-15	Apotech S.A.	Novel receptors opg-2
WO1999031128A2 (en)	1997-12-16	1999-06-24	Incyte Pharmaceuticals, Inc.	Human tumor necrosis factor-r2-like proteins
AU2093499A (en)	1997-12-30	1999-07-19	Chiron Corporation	Members of tnf and tnfr families
US6297367B1 (en)	1997-12-30	2001-10-02	Chiron Corporation	Polynucleotide encoding TNFL1
DE19809978A1 (de)	1998-03-09	1999-09-16	Basf Ag	Neuer Rezeptor aus der menschlichen Lunge
CA2324517A1 (en)	1998-03-30	1999-10-07	Eli Lilly And Company	Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the tnf receptor superfamily
EP1093516A2 (de)	1998-07-06	2001-04-25	Schering Corporation	Säugergenen; dendritische zellen prostaglandin- förmigen transporterprotein (dc-pgt), hdtea84, hsljd37r und rankl, hcc5 chemokine, deubiquitine 11 und 12 (dub11, dub12), md-1, md2 und cyclin e2, zugehörige reagenzien und verfahren
EP1135485B1 (de)	1998-12-01	2010-02-17	Genentech, Inc.	Promotion oder inhibition von angiogenese und kardiovaskularisation
EP1020521A1 (de)	1998-12-09	2000-07-19	Eli Lilly And Company	Zusammensetzungen, die Fas Ligand Inhibitor ( FLINT ) Proteine enthalten, und ihre Anwendungen
WO2000037094A2 (en)	1998-12-22	2000-06-29	Eli Lilly And Company	Therapeutic applications of flint polypeptides
WO2000046247A1 (en)	1999-02-05	2000-08-10	Merck & Co., Inc.	Methods of use for dna molecules encoding m68, a tnf receptor-related protein
EP1159286A4 (de)	1999-03-04	2003-01-15	Human Genome Sciences Inc	Tumornekrosefaktor-rezeptoren 6 alpha und 6 beta
CA2362427A1 (en)	1999-03-08	2000-09-14	Genentech, Inc.	Compositions and methods for the treatment of immune related diseases
AU3623700A (en)	1999-03-11	2000-09-28	Reinhard Ebner	Apoptosis inducing molecule ii and methods of use
CA2368760A1 (en)	1999-03-30	2000-10-05	Eli Lilly And Company	Flint polypeptide analogs
DE60036199T2 (de)	1999-03-30	2008-05-21	Eli Lilly And Co., Indianapolis	Proteaseresistente flint-analoge
AU7721500A (en)	1999-09-29	2001-04-30	Human Genome Sciences, Inc.	Colon and colon cancer associated polynucleotides and polypeptides
EP1225908A2 (de)	1999-10-20	2002-07-31	Eli Lilly And Company	Therapeutische verwendungen von flint polypeptiden
AU1915201A (en)	1999-12-07	2001-06-18	Eli Lilly And Company	Improving stability of flint through o-linked glycosylation
CA2395378A1 (en)	1999-12-09	2001-06-14	Merck & Co. Inc.	Dna molecules encoding human nhl, a dna helicase
AU2001250381A1 (en)	2000-03-15	2001-09-24	Epigenomics Ag	Diagnosis of diseases associated with tumor suppressor genes and oncogenes
AU2001266787A1 (en)	2000-06-07	2002-01-08	Human Genome Sciences, Inc.	Nucleic acids, proteins, and antibodies
WO2002000926A2 (en)	2000-06-30	2002-01-03	Epigenomics Ag	Diagnosis of diseases associated with signal transduction
WO2002009668A2 (en)	2000-08-02	2002-02-07	Eli Lilly And Company	Pulmonary administration of flint
US20030073144A1 (en)	2001-01-30	2003-04-17	Corixa Corporation	Compositions and methods for the therapy and diagnosis of pancreatic cancer
US20040176279A1 (en)	2001-02-01	2004-09-09	Nigel Jenkins	Flint glycoforms
WO2002060947A2 (en)	2001-02-01	2002-08-08	Eli Lilly And Company	Glycoforms a fas ligand inhibitory protein analog
WO2002078524A2 (en)	2001-03-28	2002-10-10	Zycos Inc.	Translational profiling
FR2908832B1 (fr)	2006-11-20	2011-08-26	Valeo Systemes Thermiques	Carter pour echangeur de chaleur

1998
- 1998-01-13 ES ES98901699T patent/ES2286843T3/es not_active Expired - Lifetime
- 1998-01-13 US US09/006,352 patent/US8003386B1/en active Active
- 1998-01-13 DE DE69837996T patent/DE69837996T2/de not_active Expired - Fee Related
- 1998-01-13 BR BR9806954A patent/BR9806954A/pt not_active IP Right Cessation
- 1998-01-13 EP EP98901699A patent/EP1007659B1/de not_active Expired - Lifetime
- 1998-01-13 CA CA002277925A patent/CA2277925A1/en not_active Abandoned
- 1998-01-13 AT AT98901699T patent/ATE365796T1/de not_active IP Right Cessation
- 1998-01-13 AU AU58157/98A patent/AU729062C/en not_active Ceased
- 1998-01-13 WO PCT/US1998/000153 patent/WO1998030694A2/en not_active Ceased
- 1998-01-13 KR KR1019997006400A patent/KR20000070174A/ko not_active Ceased
- 1998-01-13 CN CN98801836A patent/CN1247567A/zh active Pending
- 1998-01-13 JP JP53103798A patent/JP2001507937A/ja not_active Withdrawn
2000
- 2000-03-03 US US09/518,931 patent/US7186800B1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
AU5815798A (en)	1998-08-03
AU729062B2 (en)	2001-01-25
AU729062C (en)	2004-03-25
JP2001507937A (ja)	2001-06-19
DE69837996D1 (de)	2007-08-09
CA2277925A1 (en)	1998-07-16
DE69837996T2 (de)	2008-02-28
CN1247567A (zh)	2000-03-15
EP1007659A2 (de)	2000-06-14
BR9806954A (pt)	2000-03-21
KR20000070174A (ko)	2000-11-25
WO1998030694A2 (en)	1998-07-16
US7186800B1 (en)	2007-03-06
WO1998030694A3 (en)	1998-11-12
EP1007659B1 (de)	2007-06-27
ES2286843T3 (es)	2007-12-01
US8003386B1 (en)	2011-08-23

Legal Events

Date	Code	Title	Description
2010-10-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE365796T1 (de)	2007-07-15	Tumornekrosefaktor-rezeptoren 6 alpha& 6 beta
DE69841140D1 (de)	2009-10-22	Interleukin-17 rezeptor-ähnliches protein
DE69635088D1 (de)	2005-09-22	NEUTROKIN alpha
WO1998031806A3 (en)	1998-11-12	Fc receptors and polypeptides
NZ510367A (en)	2002-11-26	Interleukin 17-like receptor protein nucleic acid sequence encoding the interleukin receptor protein and method of expressing protein in recombinant vector
DE69836956D1 (de)	2007-03-15	Rezeptor 5, der eine für den zelltod verantwortliche domäne enthält
WO1998031818A3 (en)	1998-11-26	Tace-like and matrilysin-like polypeptides
EP1015468A4 (de)	2000-09-06	Follistatin-3
ATE321855T1 (de)	2006-04-15	Tumor-nekrose-faktor rezeptor 5
DE10075011I2 (de)	2004-08-12	Rezeptoren für Tumornekrosisfaktor-alpha und-beta.
DE68929043D1 (de)	1999-09-09	Für androgen-rezeptor-protein kodierende dna
EP1003767A4 (de)	2003-01-02	Menschlicher tumornekrosefaktor-rezeptor tr10
DE69434926D1 (de)	2007-04-05	Menschlicher gewebsinhibitor von metalloproteinase-4
WO2000056405A3 (en)	2001-01-04	Human tumor necrosis factor receptor-like 2
HK1042498A1 (zh)	2002-08-16	肿瘤坏死因子受体6α及6β
ATE472599T1 (de)	2010-07-15	Chemokin alpha-5
ATE300554T1 (de)	2005-08-15	Bindegewebe-wachstumsfaktor 3.
EP1187842A4 (de)	2004-03-03	Der tr10 rezeptor des menschlichen tumor-nekrose-faktors
WO2002018622A3 (en)	2002-08-29	TUMOR NECROSIS FACTOR RECEPTORS 6α AND 6$g(b)
DE60120507D1 (de)	2006-07-20	Menschliches leucinereiche wiederholungen enthaltendes protein, vorwiegend im dünndarm exprimiert, hlrrsi1
WO2000039136A3 (en)	2000-11-02	Human brainiac-5
EP1712631A3 (de)	2009-01-21	Fc Rezeptoren
WO2003031566A3 (en)	2004-04-22	Keratinocyte derived interferon
WO2001005834A9 (en)	2002-07-18	Human tumor necrosis factor receptors tr13 and tr14
MXPA03004334A (es)	2004-05-04	Receptor novedoso acoplado a proteina g humana, hgprbmy11, expresado altamente en corazon y variantes del mismo.